Arrowhead Pharmaceuticals Stock Target Price and Analyst Consensus

ARWR Stock  USD 23.67  0.34  1.42%   
The current analyst and expert consensus on Arrowhead Pharmaceuticals is Strong Buy with 4 hold recommendations. The current projected Arrowhead Pharmaceuticals target price consensus is 55.57 with 14 analyst opinions. One of the most common ways Arrowhead Pharmaceuticals analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Arrowhead Pharmaceuticals vendors, executives, and/or customers. Arrowhead Pharmaceuticals recommendation module provides expert sentiment on the projected Arrowhead Pharmaceuticals target price to derive its highest and lowest estimates based on target price standard deviation of 0.0. Check out Macroaxis Advice on Arrowhead Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.
Lowest Forecast
50.57
Highest Forecast
61.68
Target Price
55.57
As of 04/16/2024, Gross Profit is likely to grow to about 275.6 M, while Pretax Profit Margin is likely to drop (1.04). At this time, Arrowhead Pharmaceuticals' Non Current Assets Total are relatively stable compared to the past year. As of 04/16/2024, Non Currrent Assets Other is likely to grow to about 437 M, while Total Current Liabilities is likely to drop slightly above 946.1 K.
  
It's important to approach Arrowhead Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Arrowhead Pharmaceuticals price targets

Arrowhead Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Arrowhead Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Arrowhead Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Arrowhead Pharmaceuticals' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Arrowhead Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Arrowhead Pharmaceuticals is a key component of Arrowhead Pharmaceuticals valuation and have some predictive power on the future returns of a Arrowhead Pharmaceuticals.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Arrowhead Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
20.7724.6428.51
Details
Intrinsic
Valuation
LowRealHigh
22.2332.0235.89
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.95-0.163.27
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Arrowhead Pharmaceuticals. Your research has to be compared to or analyzed against Arrowhead Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Arrowhead Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Arrowhead Pharmaceuticals.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
USD Crypto Fund Idea
USD Crypto Fund
Invested one share
When determining whether Arrowhead Pharmaceuticals is a strong investment it is important to analyze Arrowhead Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Arrowhead Pharmaceuticals' future performance. For an informed investment choice regarding Arrowhead Stock, refer to the following important reports:
Check out Macroaxis Advice on Arrowhead Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Arrowhead Stock analysis

When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Commodity Directory
Find actively traded commodities issued by global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Transaction History
View history of all your transactions and understand their impact on performance
The data published in Arrowhead Pharmaceuticals' official financial statements usually reflect Arrowhead Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Arrowhead Pharmaceuticals. For example, before you start analyzing numbers published by Arrowhead accountants, it's critical to develop an understanding of what Arrowhead Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Arrowhead Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Arrowhead Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Arrowhead Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Arrowhead Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Arrowhead Pharmaceuticals' management manipulating its earnings.